Alan Ashworth's most recent trade in CytomX Therapeutics Inc was a trade of 59,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| CytomX Therapeutics Inc | Alan Ashworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2026 | 59,000 | 59,000 | - | - | Stock Option (Right to Buy) | |
| CytomX Therapeutics Inc | Alan Ashworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| CytomX Therapeutics Inc | Alan Ashworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 38,000 | 38,000 | - | - | Stock Option (Right to Buy) | |
| CytomX Therapeutics Inc | Alan Ashworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| CytomX Therapeutics Inc | Alan Ashworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 25,000 | 25,000 | - | - | Stock Option (Right to Buy) | |
| CytomX Therapeutics Inc | Alan Ashworth | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Sep 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |